Search results
NGM Bio Plunges As Experimental Drug Fails To Meet Primary Goal In Age-Related Vision Loss Disorder
Benzinga via Yahoo Finance· 2 years agoNGM Biopharmaceuticals Inc (NASDAQ: NGM) announced topline efficacy and safety results from its...
NGM Bio To Highlight Updated Preliminary Findings From Advanced Solid Tumors Trial
Benzinga via Yahoo Finance· 2 years agoNGM Biopharmaceuticals Inc's (NASDAQ: NGM) updated preliminary findings from its Phase 1a study of...
Clinical Setbacks Prompt NGM Bio Lay Off One Third Of Its Staff, Founder Leaves
Benzinga via Yahoo Finance· 1 year agoNGM Biopharmaceuticals Inc (NASDAQ: NGM) announced will be reducing its workforce by 75 staffers, or...
NGM Bio Presents Preliminary Data From NGM120 Combo Trial In Pancreatic Cancer
Benzinga via Yahoo Finance· 2 years agoNGM Biopharmaceuticals Inc (NASDAQ: NGM) announced updated preliminary findings from its Phase 1b...
NGM Biopharmaceuticals (NGM) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 9 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 0% and 42.30%,...
Bluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Zacks via Yahoo Finance· 2 years agoBluebird (BLUE) doesn't possess the right combination of the two key ingredients for a likely...